Uso de la inmunoglobulina intravenosa (IVIg) como terapia de rescate de rechazos refractarios en pacientes trasplantados renales

Casadei, Domingo H; Rial, María del C; Goldberg, Julio; Argento, Jorge; Raimondi, Eduardo; Haas, Emilio.
Rev. nefrol. diálisis transpl ; (41): 3-6, ago. 1996.
Artículo en Español | BINACIS | ID: bin-123870

Documentos relacionados

  1. Development, implementation and impact of an immunoglobulin stewardship programme in Saskatchewan, Canada.
  2. Autoantibody profiles in intravenous immunoglobulin preparations: A possible cause of mistaken autoimmunity diagnosis.
  3. Psoriasiform dermatitis following intravenous immunoglobulin therapy: A case series.
  4. Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study.
  5. Trial of Intravenous Immune Globulin in Dermatomyositis.
  6. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
  7. PlasmaCap EBA: An innovative method of isolating plasma proteins from human plasma.
  8. Restoring immune tolerance in pemphigus vulgaris.
  9. Thawed plasma (TP) as a substitute for intravenous immune globulin (IVIG) to prevent hypogammaglobulinemia post-therapeutic plasma exchange.
  10. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.